Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-28

Clinical Trial Update: The Impact of Electroacupuncture Combined With NGF on Clinical Effect and Functional Changes on Ischemic Stroke [Phase 4]

View source ↗

Summary

Phase 4 trial investigating electroacupuncture combined with nerve growth factor (NGF) for ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • electroacupuncture combined with NGF

Snippet

Sponsor: The Third Affiliated hospital of Zhejiang Chinese Medical University | Conditions: Ischemic Stroke | Phase 4 | Status: UNKNOWN